Filing Details
- Accession Number:
- 0001645627-17-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-04 15:48:48
- Reporting Period:
- 2017-05-02
- Filing Date:
- 2017-05-04
- Accepted Time:
- 2017-05-04 15:48:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
Purchased: | 29,000 shares | Avg. Price: $0.08 | Total Value: $2,333.70 |
Number of Shares After Transactions: | 20,578,949 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,550,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 700 | $0.08 | 20,551,649 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 300 | $0.08 | 20,551,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,552,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,553,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,554,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,555,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,556,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,557,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,558,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,559,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,560,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,561,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,562,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,563,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,564,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,565,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,566,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,567,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,568,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,569,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,570,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,571,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,572,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,573,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-02 | 1,000 | $0.08 | 20,574,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,575,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,576,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,577,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,578,949 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |